Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) (STAR-Too)

This study has been completed.
CF Therapeutics Development Network Coordinating Center
Seattle Children's Hospital
Washington University School of Medicine
University of Washington
University of Colorado, Denver
Baylor College of Medicine
University of Alabama at Birmingham
Cook Children's Medical Center
University of Michigan
University of Florida
University of Texas Southwestern Medical Center
Children's Hospital Medical Center, Cincinnati
St. Louis Children's Hospital
Information provided by (Responsible Party):
Marianne Muhlebach, MD, University of North Carolina, Chapel Hill Identifier:
First received: May 4, 2011
Last updated: February 10, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)